MARS1 and colorectal carcinoma: Inhibiting the K-Hcy modification by preventing HTL synthesis catalyzed by MARS resulted in decreased DNA damage and cell proliferation, suggesting the potential of MARS inhibitors (N-acetyl cysteine (NAC) and acetyl-homocysteine thioether (AHT)) in CRC treatment [69].